City

Multiple Locations (3)

Wuppertal (1)

Condition

Treatment of Venous Thromboembolism in Cancer Patients (4)

Cancer (1)

Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients (1)

Venous Thromboembolism (1)

Overall Status

Active, not recruiting (2)

Completed (2)

Sign in for free

Phase

Sponsor

Bayer (4)

Collaborator

Janssen Research & Development, LLC (3)

Intervention

rivaroxaban (xarelto, bay59-7939) (4)

low molecular weight heparin (lmwh) (2)

apixaban (1)

direct oral anticoagulants (doac) (1)

lmwh (1)

other doacs (1)

other noacs (1)

vitamin k antagonist (vka) (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Observational (4)

treatment of venous thromboembolism in cancer patients

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Gather Information About Rivaroxaban in United Kingdom Who Have

Completed

Treatment of Venous Thromboembolism in Cancer Patients

Rivaroxaban (Xarelto, BAY59-7939)
+2 more

Multiple Locations, United Kingdom

Many locations

Sep 19, 2022

Gather Information About Rivaroxaban in Sweden With Cancer Who

Active, not recruiting

Treatment of Venous Thromboembolism in Cancer Patients

Rivaroxaban (Xarelto, BAY59-7939)
+3 more

Multiple Locations, Many Locations, Sweden

Swedish registries

Aug 18, 2022

Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban

Active, not recruiting

Treatment of Venous Thromboembolism in Cancer Patients
+2 more

Rivaroxaban (Xarelto, BAY59-7939)
Apixaban

Wuppertal, Germany

Bayer

Jul 25, 2022

Cancer Associated Thrombosis for Rivaroxaban - United States

Completed

Treatment of Venous Thromboembolism in Cancer Patients
Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients

Rivaroxaban (Xarelto, BAY59-7939)
+2 more

Multiple Locations, Connecticut

Many Locations

May 18, 2022